Cegedim SA (EPA:ALCGM)
12.00
-0.15 (-1.23%)
Apr 24, 2026, 3:03 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €167.29 million as of April 24, 2026. Its market cap has increased by 8.91% in one year.
Market Cap
167.29M
Enterprise Value
416.58M
Revenue
649.17M
Ranking
n/a
PE Ratio
17.78
Stock Price
€12.00
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 167.29M, an increase of 46.94%. That is a compound annual growth rate of 1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 167.29M | -10.33% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 97.55B |
| EssilorLuxottica Société anonyme | 93.00B |
| Sartorius Stedim Biotech | 17.90B |
| Ipsen | 13.14B |
| Transgene | 206.51M |
| Sensorion | 196.37M |
| Bastide Le Confort Médical | 190.12M |
| Median Technologies | 185.19M |